Pulse 8

Veradigm, formerly known as Allscripts founded in 1986, is an integrated data systems and services company that combines data-driven clinical insights with actionable tools to help healthcare stakeholders improve the quality, efficiency, and value of healthcare delivery—these stakeholders include biopharma, health plans, healthcare providers, network partners, and most importantly, the patients they serve. Veradigm delivers a unique combination of point-of-care clinical and financial solutions, a commitment to open interoperability, a large and diverse healthcare provider footprint, along with industry proven expert insights. As a result, Veradigm attracts leaders in healthcare, technology, and innovation, seeking to work with us to deliver next-generation insights and solutions to the benefit the healthcare ecosystem with the objective being to improve healthcare quality while lowering the cost of healthcare. The Veradigm Network features proven platforms and solutions along with a dynamic community of companies providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare and advance value, insightfully. With Veradigm, Babel clients can receive enhanced support with the ability to leverage a truly end-to-end suite of products and solutions. Veradigm is focused on research, analytics, and building scalable data-driven solutions of value for ALL healthcare stakeholders. Veradigm supports biopharma companies with solutions to improve patient and provider access, accelerate life science research, and unlock key insights. Veradigm’s suite of easy-to-use healthcare technology solutions empower healthcare providers to deliver their best clinical and financial performance.

After transitioning its solutions to the Veradigm commercial brand in 2022, Allscripts is now Veradigm. Healthcare stakeholders can improve the quality, efficiency, and value of healthcare delivery with Veradigm’s data-driven clinical insights and proven solutions. Learn from thought leaders and industry experts on today’s most pressing healthcare topics, including value-based care, interoperability, reimbursements, genomics and more.

Verana Health is a digital health company that delivers quality drug lifecycle, medical practice, and medical society insights from an exclusive real-world data network of more than 20,000 clinicians. Verana Health enables CROs to round out offerings and capabilities for clinical trial enablement by leveraging our robust real-world data network and insights for study design, protocol optimization, site identification, and trial recruitment. Verana Health powers a trusted real-world data network of more than 20,000 clinicians. Verana Health is the exclusive data partner of the American Academy of Ophthalmology, American Urological Association, and American Academy of Neurology. Verana Health is partnering with leading medical societies to accelerate research with insights from some of the world's largest clinical databases in medicine. First, Verana Health is entrusted with data from the largest clinical database for ophthalmology in the U.S. Learn how real-world data can provide meaningful insights.

Verantos has conducted high-validity RWE studies for top-tier biotechnology and pharmaceutical firms, in addition to leading academic medical centers, the Food and Drug Administration, the National Institutes of Health and the National Science Foundation. Verantos believes that high-validity RWE requires a group of dedicated and highly-trained professionals who are specialists in the field. For biopharma decision-makers, Verantos is making what seemed impossible, possible. Located in California’s Silicon Valley, Verantos is a real-world evidence (RWE) company specializing in generating high-validity evidence for clinical, regulatory and reimbursement purposes. We de-identify, enrich, and integrate data from electronic health records, medical claims, and product and disease registries to produce exacting and exceptionally reliable RWE. In addition, we have vast experience within the healthcare ecosystem, including pharma, payer, provider, and regulatory. High-validity studies run on our high-validity RWE platform provide accurate and believable evidence, enabling regulatory and reimbursement approvals. Pragmatic Registry is a disease-specific registry of subjects generated from routinely collected, real-world data.

At Veridian, our goal is to present competitively priced diagnostic products of unsurpassed quality and performance designed to meet the demanding, exacting standards of today’s healthcare professionals. We are consistently working to bring new, innovative products to the market through focused brand development and strategic partnerships with new and nationally recognized industry leaders. Veridian Healthcare offers over 50 years of combined management and sales experience supporting the healthcare industry, specializing in professional and home diagnostics. Veridian Healthcare was founded in January 2009 by successful industry leaders Steve Bisulca and Mike Mazza. Veridian rapidly became one of the nation’s largest provider of diagnostic and personal health products. Combining the expertise of all these entities, Veridian can now offer “end to end” home monitoring solutions complete with devices, kitting & logistics, and software & data integration services to the healthcare industry. As a team, Veridian Healthcare offers decades of combined management, sales and technical experience supporting the healthcare industry, specializing in professional and home diagnostics, personal care products, and telehealth solutions.

We are a digital health informatics company focused on giving you power over your data through modern transparent models so that you can base sound decisions on sound predictions. We work closely with our non-profit partners, including Mederrata Research to provide value to healthcare stakeholders. During the COVID-19 pandemic, we began to productize our work that we performed both before and during the AI Challenge, building out data product pipelines and user interfaces in support of our modeling efforts.